Health
Novel neutralizing antibodies targeting SARS-CoV-2 N-terminal domain discovered – News-Medical.Net
A new study by US-based researchers shows the presence of protective antibodies that target the N-terminal domain (NTD) of the spike instead of the spike receptor-binding…
The main thrust of scientific research on therapeutics to counter the ongoing coronavirus disease 2019 (COVID-19) pandemic has been aimed at identifying drugs and antibodies that can act against the entry of the causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), into the host cell.
A new study by US-based researchers shows the presence of protective antibodies that target the N-terminal domain (NTD) of the spike instead of the spike receptor-binding domain (RBD).
The…
-
Noosa News23 hours agoHockey coach in Arana Hills charged with grooming and sexual offences against teenage girls
-
General23 hours agoWoman killed and man injured in shark attack on NSW Mid North Coast
-
Noosa News24 hours agoDepartment of Transport and Main Roads orders shutdown of North Ipswich Free Shop
-
Noosa News24 hours agoIKEA and Tekla Are Launching a Whimsical New Collection